Home > World > BRIEF-Jiangsu Nhwa: NMPA Approves NH302 Injection, NH130 Citrate Tablets Clinical Trials

BRIEF-Jiangsu Nhwa: NMPA Approves NH302 Injection, NH130 Citrate Tablets Clinical Trials

Written By: TDG Syndication
Last Updated: August 18, 2026 09:30:05 IST

Aug 18 (Reuters) – Jiangsu Nhwa Pharmaceutical Co Ltd : * SAYS NMPA APPROVES CLINICAL TRIALS OF NH302 INJECTION, NH130 CITRATE TABLETS Source text Source text Further company coverage: (Reporting by

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Latest News

The Daily Guardian is India’s fastest
growing News channel and enjoy highest
viewership and highest time spent amongst
educated urban Indians.

Follow Us

© Copyright ITV Network Ltd 2025. All right reserved.

The Daily Guardian is India’s fastest growing News channel and enjoy highest viewership and highest time spent amongst educated urban Indians.

© Copyright ITV Network Ltd 2025. All right reserved.